Trial Profile
A Randomized, Double-Blind, Placebo- and Positive-Controlled, Crossover Study to Evaluate the Abuse Potential and Safety of Orally Administered Samidorphan in Non-Dependent Recreational Opioid Users
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 06 Dec 2014
Price :
$35
*
At a glance
- Drugs Samidorphan (Primary) ; Oxycodone
- Indications CNS disorders; Substance-related disorders
- Focus Pharmacodynamics
- Sponsors Alkermes plc
- 01 Dec 2014 Status changed from recruiting to completed as reported by ClinicalTrials.gov record.
- 16 Sep 2014 New trial record